Morbidity, Recovery and Survivorship
The Morbidity, Recovery and Survivorship Working Committee provides scientific oversight for studies related to preparative regimens, prevention and treatment of early non-Graft-versus-Host Disease toxicities and supportive care in the early post-HCT/cellular therapy period as well as studies regarding issues of long-term survivors of HCT and other cellular therapies, including clinical and psychosocial effects.